We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Novel Stimulation Therapy Restores Motility to Digestive System

By HospiMedica International staff writers
Posted on 05 Dec 2018
A novel stimulation therapy restores the natural motor function of the digestive system for patients with acute gastrointestinal dysmotility (GID).

The E-Motion Medical (Tel Aviv, Israel) E-Motion System is designed to deliver unique patterns of electrical stimulation to the esophagus using a proprietary disposable feeding tube placed by nursing staff, similar to a nasogastric feeding tube. More...
By accurately sequencing of the electrical stimulation, contractions are generated in a pattern imitating natural esophageal swallowing motions, promoting motility throughout the gastrointestinal (GI) tract, preventing reflux, improving digestion, and restoring gastric emptying.

The system is comprised of the E-Motion Tube, a disposable oro/nasogastric feeding tube fitted with stainless steel electrodes along its length that delivers the stimulation to the esophageal mucosa, and the E-motion EPG 1000, a durable, touchscreen operated, bedside control unit that generates the electric stimulation pattern and sends it via the feeding tube to various locations along the esophagus. Asynchronous esophageal motion is thus induced, reducing reflux and increasing GI motility, enabling safer and better feeding.

“There is currently no adequate solution for the widespread problem of acute digestive dysmotility,” said Amichay Gross, co-founder and CEO of E-Motion Medical. “Our technology provides a new and first of its kind therapy to promote the physical function of the digestive system, and consequently improve outcomes and lower financial burden on the healthcare system.”

Acute GID manifests as reduction in, or lack of, motility in the digestive system, and is common in neurological, trauma, surgical, geriatric and also severe diabetic patients. In addition, gut motility has been shown to correlate to other physical functions in the body, including that of the diaphragm and the lungs, as well as other systems required for patient recovery.

Related Links:
E-Motion Medical


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Infant Resuscitator
Easypuff
Portable Jaundice Management Device
Nymphaea
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.